期刊文献+
共找到2篇文章
< 1 >
每页显示 20 50 100
甲状腺切除术后应用甲状腺平面显像评估残余甲状腺:与治疗剂量^(131)I扫描的对比 被引量:4
1
作者 吴书其 冯方 +5 位作者 叶智轶 吴震宇 傅宏亮 邹仁健 杜学亮 王辉 《放射免疫学杂志》 CAS 2012年第1期36-38,共3页
目的:我国常用^(99m)Tc甲状腺扫描评估甲状腺癌术后残余甲状腺大小,本文拟对甲状腺扫描与治疗剂量的^(131)I扫描进行比较分析。方法:148例(男51,女97)2年内就诊甲状腺癌术后病人入组,年龄(47.0±13.3)岁,2名核医学科医师独立、盲法... 目的:我国常用^(99m)Tc甲状腺扫描评估甲状腺癌术后残余甲状腺大小,本文拟对甲状腺扫描与治疗剂量的^(131)I扫描进行比较分析。方法:148例(男51,女97)2年内就诊甲状腺癌术后病人入组,年龄(47.0±13.3)岁,2名核医学科医师独立、盲法阅片,采用5分法计分。统计学分析采用秩相关研究,相关系数采用t检验进一步比较。结果:69/148(46.6%)两种显像结果得分一致,79(53.4%)^(131)I扫描得分高于甲扫。甲扫及^(131)I扫描评分结果与甲状腺激素水平均相关(P<0.001),且相关系数间甲扫与T_3、T_4相关程度更高(t_1=-1.933,P=0.028;t_2=-2.788,P=0.003)。结论:^(99m)Tc甲状腺平面显像可作为术后残余甲状腺的评估方法,但^(131)I扫描显示范围更大,两者与甲状腺激素水平均相关,但甲扫与其相关性可能更高。 展开更多
关键词 ~131i扫描 乳头状甲状腺癌 ~99Tc甲状腺平面显像
下载PDF
Optimal Threshold of Stimulated Serum Thyroglobulin Level for ^(18)F-FDG PET/CT imaging in Patients with Thyroid Cancer
2
作者 柴红 张虎 +1 位作者 余永利 高云朝 《Journal of Huazhong University of Science and Technology(Medical Sciences)》 SCIE CAS 2017年第3期429-432,共4页
This study was to explore the optimal threshold of thyroid-stimulating hormone(TSH)-stimulated serum thyroglobulin(s-Tg) for patients who were to receive18F-fluorodeoxyglucose(18F-FDG) PET/CT scan owing to clinical su... This study was to explore the optimal threshold of thyroid-stimulating hormone(TSH)-stimulated serum thyroglobulin(s-Tg) for patients who were to receive18F-fluorodeoxyglucose(18F-FDG) PET/CT scan owing to clinical suspicion of differentiated thyroid cancer(DTC) recurrence but negative post-therapeutic 131I whole-body scan(131I-WBS). A total of 60 qualified patients underwent PET/CT scanning from October 2010 to July 2014. The receiver operating characteristic(ROC) curve analyses showed that s-Tg levels over 49 μg/L led to the highest diagnostic accuracy of PET/CT to detect recurrence, with a sensitivity of 89.5% and a specificity of 90.9%. Besides, bivariate correlation analysis showed positive correlation between s-Tg levels and the maximum standardized uptake values(SUVmax) of18F-FDG in patients with positive PET/CT scanning, suggesting a significant influence of TSH both on Tg release and uptake of18F-FDG. So, positive PET/CT imaging is expected when patients have negative 131I-WBS but s-Tg levels over 49 μg/L. 展开更多
关键词 18F-fluorodeoxyglucose(18F-FDG) positron emission tomography/computed tomography(PET/CT) differentiated thyroid cancer(DTC) post-therapeutic 131i whole-body scan(131i-WBS) serum thyroglobulin(Tg) thyroid-stimulating hormone(TSH)
下载PDF
上一页 1 下一页 到第
使用帮助 返回顶部